FDA Adverse Event Malfunction Summary report: N

ANIMAS INSULIN INFUSION PUMP

MDR report key: 2933278 · Received January 29, 2013

Report

Report Number
2531779-2013-01288
Event Type
Malfunction
Date Received
January 29, 2013
Report Date
January 7, 2013
Manufacturer
ANIMAS CORPORATION
Product Code
LZG
PMA / PMN Number
K042873
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
PATIENT

Narratives

Additional Manufacturer Narrative · 1

THE PUMP HAS NOT BEEN RETURNED TO ANIMAS. ANIMAS HAS CONDUCTED A REVIEW OF THE DEVICE HISTORY RECORD FOR THIS PUMP AND CONFIRMED THAT IT WAS OPERATING WITHIN REQUIRED SPECIFICATIONS AT THE TIME OF RELEASE. IF THE DEVICE IS RETURNED, AN EVALUATION SHALL BE COMPLETED AND A SUPPLEMENTAL REPORT WILL BE FILED. NO CONCLUSIONS CAN BE MADE AT THIS TIME.

Additional Manufacturer Narrative · 1

FOLLOW-UP #1: DATE OF SUBMISSION 11/25/2015 DEVICE EVALUATION: THE DEVICE HAS BEEN RETURNED AND EVALUATED BY PRODUCT ANALYSIS ON (B)(4) 2015 WITH THE FOLLOWING FINDINGS: DURING INVESTIGATION, THE PUMP WAS RETURNED WITH THE CONTRAST BUTTON ON THE KEYPAD INOPERABLE WHILE ALL THE OTHER BUTTONS RESPONDED APPROPRIATELY. UNRELATED TO THE ORIGINAL COMPLAINT, THE KEYPAD WAS FOUND TO BE PEELING OFF. THE KEYPAD WAS REMOVED AND THERE WAS CONTAMINATION FOUND UNDER THE CONTRAST BUTTON. THE BATTERY COMPARTMENT WAS ALSO FOUND TO BE CRACKED ALONG THE SIDE. ANIMAS HAS CONDUCTED A REVIEW OF THE DEVICE HISTORY RECORD FOR THIS PUMP AND CONFIRMED THAT IT WAS OPERATING WITHIN REQUIRED SPECIFICATIONS AT THE TIME OF RELEASE.

Description of Event or Problem · 1

THE PATIENT CONTACTED ANIMAS ON (B)(6) 2013 AND REPORTED ISSUES WITH PRESSING THE KEYPAD BUTTONS. THERE IS NO ADVERSE EVENT ASSOCIATED WITH THIS COMPLAINT. THIS COMPLAINT IS BEING REPORTED DUE TO THE ALLEGED KEYPAD RESPONSE ISSUE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
39835 ANIMAS INSULIN INFUSION PUMP INSULIN INFUSION PUMP LZG ANIMAS CORPORATION ANM 2020 INSULIN INFUSION PUMP

Patients

Seq Age Sex Outcome Treatment
1 65 YR